FTIS
VRTX icon

First Trust Investment Solutions’s Vertex Pharmaceuticals VRTX Stock Holding History

First Trust Investment Solutions’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$204K Buy
438
+11
+3% +$5.28K 0.02% 272
2024
Q2 		$200K Buy
+427
New +$185K 0.03% 249

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

First Trust Investment Solutions's VRTX Position: Q3 2024 in Review

First Trust Investment Solutions increased its Vertex Pharmaceuticals (VRTX) stake by 2.6% in Q3 2024, buying an estimated $5.28K and bringing the position to 438 shares worth $204K. The position accounts for 0.02% of the portfolio, ranked #272.

First Trust Investment Solutions first reported a position in VRTX in Q2 2024 and has held it in 2 quarters since. 1,544 funds tracked by Wall St. Rank hold VRTX as of Q3 2024.

  • First Trust Investment Solutions held 438 shares of Vertex Pharmaceuticals worth $204K as of Q3 2024.
  • First Trust Investment Solutions bought 11 Vertex Pharmaceuticals shares in Q3 2024, an estimated $5.28K.
  • Vertex Pharmaceuticals made up 0.02% of First Trust Investment Solutions's portfolio in Q3 2024, its #272 holding.
  • First Trust Investment Solutions first reported a position in Vertex Pharmaceuticals in Q2 2024 and has held it in 2 quarters since.
  • 1,544 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2024.

Based on First Trust Investment Solutions's 13F filing for Q3 2024, filed 13 Nov 2024.